Covered recipient · General Payments record
MARLENA J HARRIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Anesthetist, Certified Registered
General Payments · PY2021
$246.39
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $246.39 | 18 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $117.69 | 6 |
| ABBVIE INC. | $112.90 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.80 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $246.39 | 18 |
Payment records · PY2021 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $7.20 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446121 | CMS |
| AbbVie Inc. | $13.91 | 02/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446127 | CMS |
| AbbVie Inc. | $20.50 | 03/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446131 | CMS |
| AbbVie Inc. | $12.46 | 03/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446135 | CMS |
| AbbVie Inc. | $14.47 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446139 | CMS |
| AbbVie Inc. | $4.68 | 03/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446143 | CMS |
| AbbVie Inc. | $3.51 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446147 | CMS |
| AbbVie Inc. | $13.23 | 05/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446151 | CMS |
| AbbVie Inc. | $9.22 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446155 | CMS |
| AbbVie Inc. | $4.88 | 06/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446159 | CMS |
| AbbVie Inc. | $8.84 | 08/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794446163 | CMS |
| GlaxoSmithKline, LLC. | $14.32 | 01/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801879215 | CMS |
| GlaxoSmithKline, LLC. | $21.30 | 02/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801882865 | CMS |
| GlaxoSmithKline, LLC. | $17.04 | 03/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802890937 | CMS |
| GlaxoSmithKline, LLC. | $17.81 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802574549 | CMS |
| GlaxoSmithKline, LLC. | $22.05 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801885489 | CMS |
| GlaxoSmithKline, LLC. | $25.17 | 06/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801912923 | CMS |
| Novartis Pharmaceuticals Corporation | $15.80 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 814470647 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.